Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 12 hours agoBut the competitor vaccines have full FDA approval. Meanwhile, Novavax's shot has been available in...
Novavax says it will have an updated Covid vaccine - Washington Business Journal
The Business Journals· 2 days ago(NASDAQ: NVAX) says it will have an updated Covid-19 vaccine ready in the fall, after a Food...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 12 hours agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 3 days agoIdeally, these updated vaccines will be available in the fall. The Vaccines and Related Biological...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 2 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
A New COVID Booster Targeting JN.1 May Arrive This Fall
Verywell Health via Yahoo News· 13 hours agoAn FDA panel voted to recommend an updated COVID-19 vaccine targeting the JN.1 variant. Here's what...
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
InvestorPlace· 2 days agoVaccine maker Novavax (NASDAQ:NVAX) saw its shares jump 18% on June 5 and another 20% in pre-market...
Will there be a new Covid vaccine in the fall?
NBC News via Yahoo News· 2 days agoNovavax said it’s on track to have an updated vaccine that targets JN.1 available in August. However, should the FDA select a different strain, the...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines - ABC17NEWS
ABC17 NEWS· 2 days agoBy LAURAN NEERGAARD AP Medical Writer WASHINGTON (AP) — Government advisers say it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall ...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 3 days agoDrug manufactures Moderna, Pfizer and Novavax said they expect the new vaccines will be available...